Magnetic susceptibility as a 1-year predictor of outcome in familial cerebral cavernous malformations: a pilot study

[1]  R. Shenkar,et al.  Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth , 2021, Journal of magnetic resonance imaging : JMRI.

[2]  V. Torri,et al.  Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial , 2020, Trials.

[3]  Justin M. Moore,et al.  Role of aspirin and statin therapy in patients with cerebral cavernous malformations , 2020, Journal of Clinical Neuroscience.

[4]  C. McCulloch,et al.  Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial , 2019, Translational Stroke Research.

[5]  R. Shenkar,et al.  A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease , 2019, Translational Stroke Research.

[6]  Richard E Thompson,et al.  Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage , 2018, Journal of magnetic resonance imaging : JMRI.

[7]  T. Hirai,et al.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care , 2017, Journal of magnetic resonance imaging : JMRI.

[8]  C. Jack,et al.  Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging , 2017, JAMA neurology.

[9]  D. Kondziolka,et al.  Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel , 2017, Neurosurgery.

[10]  Hongjiang Wei,et al.  Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications , 2015, Tomography.

[11]  D. Zanon,et al.  Propranolol for Cerebral Cavernous Angiomatosis , 2014, Clinical pediatrics.

[12]  Pascal Spincemaille,et al.  Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. , 2012, Radiology.

[13]  Yi Wang,et al.  A novel background field removal method for MRI using projection onto dipole fields (PDF) , 2011, NMR in biomedicine.

[14]  Yi Wang,et al.  Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging , 2010, Magnetic resonance in medicine.